Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).
CYBB
Chronic granulomatous disease
G6PD
Mutation
NADPH oxidase
X-linked disease
gp91(phox)
Journal
Blood cells, molecules & diseases
ISSN: 1096-0961
Titre abrégé: Blood Cells Mol Dis
Pays: United States
ID NLM: 9509932
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
27
05
2021
accepted:
28
05
2021
pubmed:
28
6
2021
medline:
1
2
2022
entrez:
27
6
2021
Statut:
ppublish
Résumé
Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. CGD patients suffer from severe bacterial and fungal infections. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase. Superoxide and subsequently formed other reactive oxygen species (ROS) are instrumental in killing phagocytosed micro-organisms in neutrophils, eosinophils, monocytes and macrophages. The leukocyte NADPH oxidase is composed of five subunits, of which the enzymatic component is gp91
Identifiants
pubmed: 34175765
pii: S1079-9796(21)00053-X
doi: 10.1016/j.bcmd.2021.102587
pii:
doi:
Substances chimiques
CYBB protein, human
EC 1.6.3.-
NADPH Oxidase 2
EC 1.6.3.-
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102587Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.